CryoPort Updates Extreme Conditions Pilot Program

Potential Client Requests Company to Provide Plan for Pan-Asian Markets

LAKE FOREST, CA -- (MARKET WIRE) -- 07/22/08 -- CryoPort, Inc. ( (OTCBB: CYRX), a leading supplier of affordable temperature sensitive shipping solutions for the frozen biopharmaceutical industry, today announced the extreme conditions testing in India is currently ongoing.

"The results of our trial have been very good. Based on the already completed portions of this and other pilot programs, this particular potential client has asked us to focus our efforts on developing a plan for the entire Asia Pacific region," stated Peter Berry, CEO of CryoPort.

The Extreme Conditions Pilot has focused on demonstrating the effectiveness of the CryoPort Express(TM) Shipper under what are likely to be the most difficult conditions that the shipper will face. It is also helping the company to establish and understand local protocols and logistical bottlenecks.

"We expect that our first rollout of the Express Shipper will be as a direct result of the success so far in these trials along with others in this region. We anticipate that once we have finalized an agreement, the Express Shipper will begin rolling out in the Asia Pacific markets," continued Mr. Berry.

About CryoPort

CryoPort ( develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.


This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Stuart Fine
Carpe DM, Inc.